Kaposi sarcoma: review and medical management update

被引:64
作者
Fatahzadeh, Mahnaz [1 ]
机构
[1] Univ Med & Dent New Jersey, New Jersey Dent Sch, Div Oral Med, Dept Diagnost Sci, Newark, NJ 07103 USA
来源
ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY | 2012年 / 113卷 / 01期
关键词
HUMAN-IMMUNODEFICIENCY-VIRUS; ACTIVE ANTIRETROVIRAL THERAPY; RECONSTITUTION INFLAMMATORY SYNDROME; REVERSE-TRANSCRIPTASE INHIBITORS; PEGYLATED-LIPOSOMAL DOXORUBICIN; HHV8 ASSOCIATED DISEASES; HIV-INFECTED PATIENTS; OF-THE-ART; HUMAN-HERPESVIRUS-8; INFECTION; IMMUNE RECONSTITUTION;
D O I
10.1016/j.tripleo.2011.05.011
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
Despite recent advances in our understanding of pathogenic mechanisms involved, the true nature of Kaposi sarcoma remains an enigma. Four clinical variants have been described for the disease, differing in natural history, site of predilection, and prognosis. All forms of Kaposi sarcoma may manifest in the oral cavity and Kaposi sarcoma-associated virus appears essential to development of all clinical variants. The spectrum of therapeutic strategies is broad and selection of appropriate intervention mandates a thorough understanding of disease spread and the patient's symptomatology, as well as risks and benefits of therapy. This article provides an overview of epidemiology, subtypes, clinical course, pathogenesis, and management strategies for Kaposi sarcoma. (Oral Surg Oral Med Oral Pathol Oral Radiol 2012;113:2-16)
引用
收藏
页码:2 / 16
页数:15
相关论文
共 191 条
[1]   Spectrum of Kaposi's sarcoma-associated herpesvirus, or human herpesvirus 8, diseases [J].
Ablashi, DV ;
Chatlynne, LG ;
Whitman, JE ;
Cesarman, E .
CLINICAL MICROBIOLOGY REVIEWS, 2002, 15 (03) :439-+
[2]   The epidemiologic, pathologic, and clinical features of AIDS-associated pulmonary Kaposi's sarcoma [J].
Aboulafia, DM .
CHEST, 2000, 117 (04) :1128-1145
[3]   Therapeutic strategies for epidemic Kaposi's sarcoma [J].
Aldenhoven, M. ;
Barlo, N. P. ;
Sanders, C. J. G. .
INTERNATIONAL JOURNAL OF STD & AIDS, 2006, 17 (09) :571-578
[4]  
[Anonymous], 1872, Arch Derm Syphilol, DOI DOI 10.1007/BF01830024
[5]   Kaposi's sarcoma [J].
Antman, K ;
Chang, Y .
NEW ENGLAND JOURNAL OF MEDICINE, 2000, 342 (14) :1027-1038
[6]   Treatments of AIDS-related Kaposi's sarcoma [J].
Aversa, SML ;
Cattelan, AM ;
Salvagno, L ;
Crivellari, G ;
Banna, G ;
Trevenzoli, M ;
Chiarion-Sileni, V ;
Monfardini, S .
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2005, 53 (03) :253-265
[7]   Kaposi's sarcoma-associated herpesvirus transmission and primary infection [J].
Bagni, Rachel ;
Whitby, Denise .
CURRENT OPINION IN HIV AND AIDS, 2009, 4 (01) :22-26
[8]   Imatinib interferes with survival of multi drug resistant Kaposi's sarcoma cells [J].
Basciani, Sabrina ;
Vona, Rosa ;
Matarrese, Paola ;
Ascione, Barbara ;
Mariani, Stefania ;
Gnessi, Lucio ;
Malorni, Walter ;
Straface, Elisabetta .
FEBS LETTERS, 2007, 581 (30) :5897-5903
[9]   Kaposi's sarcoma-associated herpesvirus-specific immune reconstitution and antiviral effect of combined HAART/chemotherapy in HIV clade C-infected individuals with Kaposi's sarcoma [J].
Bihl, Florian ;
Mosam, Anisa ;
Henry, Leah N. ;
Chisholm, John V., III ;
Dollard, Sheila ;
Gumbi, Pamela ;
Cassol, Edana ;
Page, Taryn ;
Mueller, Nicolas ;
Kiepiela, Photini ;
Martin, Jeff N. ;
Coovadia, Hoosen A. ;
Scadden, David T. ;
Brander, Christian .
AIDS, 2007, 21 (10) :1245-1252
[10]   Phase III vehicle-controlled, multi-centered study of topical alitretinoin gel 0.1% in cutaneous AIDS-related Kaposi's sarcoma [J].
Bodsworth N.J. ;
Block M. ;
Bower M. ;
Donnell D. ;
Yocum R. .
American Journal of Clinical Dermatology, 2001, 2 (2) :77-87